MiRus today announced successful enrollment and treatment of the first patients in the STAR Trial, a prospective, multicenter ...

PuraPly® AM is a patent-protected product that is differentiated among all skin substitutes by combining a native, cross-linked collagen matrix with polyhexamethylene biguanide (PHMB) antimicrobial to ...

A new working paper finds that preschool classrooms where teachers received an intervention designed to strengthen curriculum implementation, effective teaching practices, and teachers' engagement ...

Organogenesis Holdings Inc. ORGO shares are up during Tuesday’s premarket session following the company’s announcement of achieving the primary endpoint in a randomized controlled trial evaluating ...

Organogenesis Holdings Inc. (NASDAQ:ORGO) shares surged about 20% on Tuesday after the company reported that its PuraPly AM treatment met the primary endpoint in a randomized controlled trial ...

Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial ...

Importance Women with angina due to suspected ischaemia referred for coronary angiography often have no obstructive coronary ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...